Skip to main content
. 2021 May 6;17(4):423–434. doi: 10.4103/jmas.JMAS_219_20

Table 4.

Evaluation of publication bias of included studies

Outcomes Subgroup No. studies Begg’s Test Egger’s test

Pr>|z|□ Pr > |z|□□ P>|t| □
Operative time (min) RCT 8 0.458 0.536 0.831
RCS 23 0.937 0.958 0.735
Proximal resection margin RCT 3 0.602 1 0.939
RCS 8 0.621 0.711 0.474
Distal resection margin (cm) RCT 3 0.602 1 0.791
RCS 7 0.368 0.453 0.97
Hospital stay (d) RCT 7 0.453 0.548 0.697
RCS 19 0.916 0.944 0.107
Estimated blood loss (ml) RCT 6 0.188 0.26 0.376
RCS 20 0.27 0.284 0.078
Intraoperative transfusion RCT 3 0.602 1 0.165
RCS 7 0.453 0.548 0.201
Time to oral intake (d) RCT 6 0.851 1 0.782
RCS 14 0.622 0.661 0.53
Time to first flatus (d) RCT 7 0.652 0.764 0.477
RCS 15 0.181 0.198 0.099
Time to ambulation (d) RCT 4 0.174 0.308 0.545
RCS 7 0.881 1 0.88
Overall complications RCT 7 0.881 1 0.616
RCS 26 0.343 0.355 0.724
Serious complications RCT 6 0.188 0.26 0.177
RCS 11 0.436 0.484 0.168
Lymph node dissection RCT 8 0.536 0.621 0.614
RCS 21 0.856 0.88 0.777
R0 rate RCT 2 0.317 1 *
RCS 7 0.09 0.174 0.056
Recurrence rate RCT 3 0.602 1 0.275
RCS 13 0.18 0.2 0.195
3-year DFS RCS 4 0.174 0.308 0.054
3-year OS RCS 9 0.297 0.348 0.212
5-year DFS RCS 13 0.222 0.246 0.166
5-year OS RCS 17 0.249 0.266 0.334

RCT: Randomized controlled study, RCS: Retrospective cohort study, OS-overall survival, DFS: Disease free survival; *P; **P (continuity corrected). *NA: Not available, Supplementary file 3 Evaluation of publication bias of included studies